A phase 2 single-arm study of berzosertib in combination with irinotecan in patients with progressive TP53 mutant gastric and gastro-esophageal junction cancer

被引：0
|
作者：
Stockton, Shannon
Soares, Heloisa P.
Dayyani, Farshid
Saeed, Anwaar
Kim, Edward S.
Jin, Ning
Yacoub, George Hosni
Whisenant, Jennifer
Ayers, G. Dan
Gore, Steven
Das, Satya
Berlin, Jordan
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Univ Utah, Hunstman Canc Hosp, Salt Lake City, UT USA
[3] Univ Calif Irvine, Div Hematol Oncol, Dept Med, Orange, CA USA
[4] UPMC, Dept Med, Div Hematol & Oncol, UPMC Hillman Canc Ctr, Pittsburgh, PA USA
[5] City Hope Natl Med Ctr, Irvine, CA USA
[6] Ohio State Univ, Wexner Med Ctr, Columbus, OH USA
[7] Wake Forest Univ, Dept Gen Internal Med, Winston Salem, NC USA
[8] NCI, Rockville, MD USA
[9] Astra Zeneca, Gaithersburg, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4044
引用
收藏
页数：1
相关论文
共 50 条
  • [21] First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial
    Cytryn, Samuel L.
    Moy, Ryan H.
    Cowzer, Darren
    Shah, Ronak H.
    Chou, Joanne F.
    Joshi, Smita S.
    Ku, Geoffrey Y.
    Maron, Steven B.
    Desai, Avni
    Yang, Jessica
    Sugarman, Ryan
    Rao, Devika
    Goldberg, Zoe
    Charalambous, Carmelina
    Lapshina, Maria
    Antoine, Ariel
    Socolow, Fiona
    Trivedi, Nikhil
    Capanu, Marinela
    Gerdes, Hans
    Schattner, Mark A.
    Simmons, Marc
    Lacouture, Mario E.
    Paroder, Viktoriya
    Tang, Laura H.
    Shia, Jinru
    Ilson, David H.
    Solit, David B.
    Berger, Michael F.
    Janjigian, Yelena Y.
    LANCET ONCOLOGY, 2023, 24 (10): : 1073 - 1082
  • [22] Multi-center Phase II Trial of Weekly Paclitaxel Plus Cisplatin Combination Chemotherapy in Patients with Advanced Gastric and Gastro-esophageal Cancer
    Sun, Qing
    Liu, Chaoying
    Zhong, Haijun
    Zhong, Baoliang
    Xu, Haiyuan
    Shen, Wenxiang
    Wang, Daoyuan
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (04) : 237 - 243
  • [23] Ramucirumab effectiveness in patients with advanced gastric cancer or gastro-esophageal junction adenocarcinoma in clinical practice in Spain: Sub-analysis of RAMIS study
    Longo, F.
    Jorge Fernandez, M.
    Yaya Tur, R.
    Fernandez Montes, A.
    Martinez Lago, N.
    Brozos Vazquez, E.
    Aparicio Urtasun, J.
    Quintero Aldana, G.
    Ceballos Barbancho, E.
    Buxo Orra, E.
    Lopez Munoz, A.
    Pellon Augusto, M.
    Molina Villaverde, R.
    Diaz-Paniagua, L.
    Cerda Serda, P.
    Lopez-Leiva, P.
    Martin-Carnicero, A.
    Cousillas Castineiras, A.
    Paris Bouzas, L.
    Garcia Paredes, B.
    Romero Reinoso, C.
    Ortega Sedano, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S103 - S103
  • [24] Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial (vol 30, pg 552, 2024)
    Yuan, Shu-Qiang
    Nie, Run-Cong
    Jin, Ying
    Liang, Cheng-Cai
    Li, Yuan-Fang
    Jian, Rui
    Sun, Xiao-Wei
    Chen, Ying-Bo
    Guan, Wen-Long
    Wang, Zi-Xian
    Qiu, Hai-Bo
    Wang, Wei
    Chen, Shi
    Zhang, Dong-Sheng
    Ling, Yi-Hong
    Xi, Shao-Yan
    Cai, Mu-Yan
    Huang, Chun-Yu
    Yang, Qiu-Xia
    Liu, Zhi-Min
    Guan, Yuan-Xiang
    Chen, Yong-Ming
    Li, Ji-Bin
    Tang, Xiong-Wen
    Peng, Jun-Sheng
    Zhou, Zhi-Wei
    Xu, Rui-Hua
    Wang, Feng
    NATURE MEDICINE, 2024, 30 (02) : 605 - 605
  • [25] Docetaxel, oxaliplatin and capecitabine (TEX regimen) in patients with metastatic gastric or gastro-esophageal cancer: Results of a multicenter phase I/II study
    Stein, Alexander
    Arnold, Dirk
    Thuss-Patience, Peter C.
    Moehler, Markus
    Grothe, Wilfried
    Seufferlein, Thomas
    Reinacher-Schick, Anke
    Geissler, Michael
    Hofheinz, Ralf-Dieter
    Schmoll, Hans-Joachim
    ACTA ONCOLOGICA, 2014, 53 (03) : 392 - 398
  • [26] Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ)
    Ryan, D. P.
    Murphy, J.
    Mahalingam, D.
    Strickler, J.
    Stein, S.
    Sirard, C.
    Landau, S.
    Bendell, J.
    ANNALS OF ONCOLOGY, 2016, 27 : 108 - 108
  • [27] QUALITY OF LIFE RESULTS FROM A PHASE III STUDY OF TRASTUZUMAB PLUS CHEMOTHERAPY AS FIRST-LINE THERAPY IN PATIENTS WITH HER2-POSITIVE ADVANCED GASTRIC AND GASTRO-ESOPHAGEAL JUNCTION CANCER
    Ohtsu, A.
    Wang, L.
    Lim, H.
    Gourbounova, V
    Bang, Y.
    Van Cutsem, E.
    Al-Sakaff, N.
    Lehle, M.
    Hill, J.
    de Mendoza, Hurtado F.
    ANNALS OF ONCOLOGY, 2010, 21 : 14 - 14
  • [28] First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial
    Janjigian, Yelena Y.
    Maron, Steven B.
    Chatila, Walid K.
    Millang, Brittanie
    Chavan, Shweta S.
    Alterman, Carly
    Chou, Joanne F.
    Segal, Michal F.
    Simmons, Marc Z.
    Momtaz, Parisa
    Shcherba, Marina
    Ku, Geoffrey Y.
    Zervoudakis, Alice
    Won, Elizabeth S.
    Kelsen, David P.
    Ilson, David H.
    Nagy, Rebecca J.
    Lanman, Richard B.
    Ptashkin, Ryan N.
    Donoghue, Mark T. A.
    Capanu, Marinela
    Taylor, Barry S.
    Solit, David B.
    Schultz, Nikolaus
    Hechtman, Jaclyn F.
    LANCET ONCOLOGY, 2020, 21 (06): : 821 - 831
  • [29] Trastuzumab Combined with Irinotecan in Patients with HER2-Positive Metastatic Colorectal Cancer: A Phase II Single-Arm Study and Exploratory Biomarker Analysis
    Xu, Ting
    Wang, Xicheng
    Xin, Ying
    Wang, Zhenghang
    Gong, Jifang
    Zhang, Xiaotian
    Li, Yanyan
    Ji, Congcong
    Sun, Yu
    Zhao, Feilong
    Huang, Depei
    Bai, Yuezong
    Li, Jian
    Shen, Lin
    CANCER RESEARCH AND TREATMENT, 2023, 55 (02): : 626 - 635
  • [30] Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma:: results of a randomized phase II study
    Pozzo, C
    Barone, C
    Szanto, J
    Padi, E
    Pesche, C
    Bükki, J
    Gorbunova, V
    Valvere, V
    Zaluski, J
    Biakhov, M
    Zuber, E
    Jacques, C
    Bugat, R
    ANNALS OF ONCOLOGY, 2004, 15 (12) : 1773 - 1781
12345